{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "host directed therapeutic",
      "nonhuman primate",
      "tuberculosis",
      "vaccine"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "28575319",
  "DateCompleted": {
    "Year": "2018",
    "Month": "11",
    "Day": "19"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "12",
    "Day": "04"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1093/ilar/ilx015"
    ],
    "Journal": {
      "ISSN": "1930-6180",
      "JournalIssue": {
        "Volume": "58",
        "Issue": "2",
        "PubDate": {
          "Year": "2017",
          "Month": "Dec",
          "Day": "01"
        }
      },
      "Title": "ILAR journal",
      "ISOAbbreviation": "ILAR J"
    },
    "ArticleTitle": "Translational Research in the Nonhuman Primate Model of Tuberculosis.",
    "Pagination": {
      "StartPage": "151",
      "EndPage": "159",
      "MedlinePgn": "151-159"
    },
    "Abstract": {
      "AbstractText": [
        "Infection with Mycobacterium tuberculosis predominantly establishes subclinical latent infection over the lifetime of an individual, with a fraction of infected individuals rapidly progressing to active disease. The immune control in latent infection can be perturbed by comorbidities such as diabetes mellitus, obesity, smoking, and coinfection with helminthes or HIV. Modeling the varying aspects of natural infection remains incomplete when using zebrafish and mice. However, the nonhuman primate model of tuberculosis offers a unique and accurate model to investigate host responses to infection, test novel therapeutics, and thoroughly assess preclinical vaccine candidates. Rhesus macaques and cynomolgus macaques manifest the full gamut of clinical and pathological findings in human Mycobacterium tuberculosis infection, including the ability to co-infect macaques with Simian Immunodeficiency Virus to model HIV co-infection. Here we discuss advanced techniques to assay various clinical outcomes of the natural progression of infection as well as therapeutics in development and novel preclinical vaccines. Finally, we survey the translational aspects of nonhuman primate research and argue the urgent need to thoroughly examine preclinical therapeutics and vaccines using this model prior to clinical implementation."
      ],
      "CopyrightInformation": "\u00a9 The Author(s) 2017. Published by Oxford University Press on behalf of the National Academy of Sciences. All rights reserved. For permissions, please email: journals.permissions@oup.com."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Tulane National Primate Research Center, Covington, Louisiana."
          },
          {
            "Identifier": [],
            "Affiliation": "Tulane University School of Medicine, New Orleans, Louisiana."
          }
        ],
        "LastName": "Foreman",
        "ForeName": "Taylor W",
        "Initials": "TW"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Louisiana State University School, Veterinary Medicine, Baton Rouge, Louisiana."
          },
          {
            "Identifier": [],
            "Affiliation": "Tulane National Primate Research Center in Covington, Louisiana."
          }
        ],
        "LastName": "Mehra",
        "ForeName": "Smriti",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Tulane National Primate Research Center, Covington, Louisiana."
          },
          {
            "Identifier": [],
            "Affiliation": "Immunology and Pathology at Tulane University School of Medicine in New Orleans, Louisiana."
          }
        ],
        "LastName": "Lackner",
        "ForeName": "Andrew A",
        "Initials": "AA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Tulane National Primate Research Center, Covington, Louisiana."
          },
          {
            "Identifier": [],
            "Affiliation": "Immunology at Tulane University School of Medicine, New Orleans, Louisiana."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Medicine, Tulane University School of Medicine in New Orleans, Louisiana."
          }
        ],
        "LastName": "Kaushal",
        "ForeName": "Deepak",
        "Initials": "D"
      }
    ],
    "GrantList": [
      {
        "GrantID": "UC6 AI058609",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R21 AI127222",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 AI111943",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "P51 OD011104",
        "Acronym": "OD",
        "Agency": "NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R21 AI127160",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "P30 GM110760",
        "Acronym": "GM",
        "Agency": "NIGMS NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 AI089323",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R21 RR026006",
        "Acronym": "RR",
        "Agency": "NCRR NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "ILAR J",
    "NlmUniqueID": "9516416",
    "ISSNLinking": "1084-2020"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Coinfection"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "HIV Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Macaca mulatta"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mice"
    },
    {
      "QualifierName": [
        "pathogenicity"
      ],
      "DescriptorName": "Mycobacterium tuberculosis"
    },
    {
      "QualifierName": [
        "pathogenicity"
      ],
      "DescriptorName": "Simian Immunodeficiency Virus"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Translational Research, Biomedical"
    },
    {
      "QualifierName": [
        "immunology",
        "microbiology"
      ],
      "DescriptorName": "Tuberculosis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Zebrafish"
    }
  ]
}